All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @itsleidytejada on TikTok · 23s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @itsleidytejada's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00A gamut la sopau s'empicotrames, para kestez comon palo de tiriguillo de aquí abirano.
  2. 0:04Necessitas, repojo ahi, pimento comon de jamis.
  3. 0:07Ajo, lemon, sevoja, cilantro, and to

"Ozempic soup" trend: food fad or actual GLP-1 science?

Leidy

TikTok creator

1.1M viewsWatch on TikTok

Quick answer

The video promotes a vegetable-based soup recipe under the "Ozempic" label, implying food-based GLP-1 mimicry. None of the listed ingredients (cabbage, bell pepper, cumin, garlic, lemon, onion, cilantro, ham) have clinical evidence supporting GLP-1 receptor agonist activity at culinary doses. Patients seeking weight management should be evaluated by a licensed clinician to determine whether FDA-approved GLP-1 therapies are appropriate for their individual metabolic profile.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For "Ozempic soup" trend: food fad or actual GLP-1 science?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to ""Ozempic soup" trend: food fad or actual GLP-1 science?" from Leidy. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video promotes a vegetable-based soup recipe under the "Ozempic" label, implying food-based GLP-1 mimicry.

The reason this review is not generic is the source wording and the canonical claim label "glp1 sopa ozempic si paratiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii bajarde." In this clip, the useful excerpt is: "A gamut la sopau s'empicotrames, para kestez comon palo de tiriguillo de aquí abirano." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Fiber intake can modestly stimulate the body's own GLP-1 secretion through normal gut physiology, per Chambers et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video promotes a vegetable-based soup recipe under the "Ozempic" label, implying food-based GLP-1 mimicry.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video promotes a vegetable-based soup recipe under the "Ozempic" label, implying food-based GLP-1 mimicry. None of the listed ingredients (cabbage, bell pepper, cumin, garlic, lemon, onion, cilantro, ham) have clinical evidence supporting GLP-1 receptor agonist activity at culinary doses. Patients seeking weight management should be evaluated by a licensed clinician to determine whether FDA-approved GLP-1 therapies are appropriate for their individual metabolic profile.
  • 0 clinical trials support any food recipe replicating semaglutide or tirzepatide receptor binding activity.
  • Fiber intake can modestly stimulate the body's own GLP-1 secretion through normal gut physiology, per Chambers et al. (2015, Gut), but this is not pharmacologically equivalent to GLP-1 medications.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • 0 clinical trials support any food recipe replicating semaglutide or tirzepatide receptor binding activity.
  • Fiber intake can modestly stimulate the body's own GLP-1 secretion through normal gut physiology, per Chambers et al. (2015, Gut), but this is not pharmacologically equivalent to GLP-1 medications.
  • Garlic has shown mild fasting glucose reductions in meta-analysis (Ried et al., 2016, Journal of Nutrition), but these effects are modest and do not translate to drug-equivalent weight loss.
  • The 'Ozempic soup' label on social media is a marketing frame with no clinical or regulatory basis, not a description of biochemical activity.
  • Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are FDA-approved prescription medications. Their use requires clinician evaluation, not recipe substitution.
  • A vegetable broth is a reasonable low-calorie meal, particularly for patients already on GLP-1 therapy managing digestive tolerance, but it works as a light food, not as a drug mimic.
  • Videos implying food-based GLP-1 equivalence at 1.1 million views can delay patients from seeking appropriate medical evaluation for weight management or type 2 diabetes.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @itsleidytejada actually say?

The creator posted a recipe video under the label "Sopa Ozempic" — Ozempic soup — and listed ingredients including cabbage, bell pepper, cumin, ham, garlic, lemon, onion, and cilantro. The transcript is partially unclear, but the framing is unmistakable: this soup is being positioned as a food-based alternative or companion to GLP-1 medications like semaglutide.

To be fair, she does not explicitly claim the soup injects you with semaglutide or replaces an Ozempic prescription. The implicit message, though, is that eating this combination of ingredients produces weight-loss effects similar to GLP-1 drugs. That framing is what needs scrutiny. At 1.1 million views, the implied promise does real work whether or not the words spell it out.

Does the science back this up?

No, not in any meaningful way. None of the ingredients listed have clinical evidence showing they replicate GLP-1 receptor agonist activity in humans at the doses you would get from a soup.

Some of the ingredients do have legitimate, modest metabolic research behind them. Garlic (Allium sativum) has been studied for mild glucose-lowering effects, with a 2016 meta-analysis by Ried et al. in the Journal of Nutrition finding modest fasting glucose reductions. Capsaicin in bell peppers has been linked to small appetite-suppressing effects in short-term trials (Janssens et al., 2013, PLOS ONE). Lemon flavonoids have shown some insulin-sensitizing properties in animal models, but human data is weak.

None of this is the same as GLP-1 receptor activation. Semaglutide works by binding to GLP-1 receptors in the pancreas and hypothalamus, slowing gastric emptying and suppressing appetite through a specific pharmacological mechanism. A cabbage-and-cumin broth does not do that. Calling it "Sopa Ozempic" is a marketing frame, not a biochemical description.

What did they get wrong (or right)?

Wrong: the name. Calling any food "Ozempic soup" implies a pharmacological equivalence that does not exist. This is a common and genuinely harmful pattern on health-adjacent social media. People delay or skip actual treatment because they believe a soup or supplement is doing the same job. It is not.

Probably right: the ingredients themselves are not dangerous, and a vegetable-heavy broth with lean protein (ham aside, given sodium content) is a reasonable low-calorie meal. If someone on semaglutide is looking for foods that are easy on a slowed digestive system, something like this is not a bad choice, not because it mimics the drug, but because it is light, warm, and low in fat.

Also worth noting: the recipe as described is high in fiber and relatively low in calorie density. Those are characteristics that can support satiety. But that is true of most vegetable soups. The Ozempic branding adds nothing real and misleads a lot.

What should you actually know?

GLP-1 receptor agonists are prescription medications approved by the FDA for type 2 diabetes management (semaglutide under Ozempic) and chronic weight management (semaglutide under Wegovy, tirzepatide under Zepbound). Their effects on appetite, gastric emptying, and weight are the result of specific receptor binding that no food currently replicates.

That does not mean food is irrelevant. Research published by Hjorth et al. (2017, American Journal of Clinical Nutrition) suggests higher-protein, lower-glycemic diets support better outcomes in people with insulin resistance. A 2023 review in Obesity Reviews noted that dietary fiber intake correlates with endogenous GLP-1 secretion, meaning fiber-rich foods may mildly stimulate your body's own GLP-1 production, not through any drug-like mechanism, just normal gut physiology.

So eat the soup if you like it. Just do not eat it instead of talking to a clinician about whether a GLP-1 medication is appropriate for you.

  • No food ingredient reproduces the pharmacological action of semaglutide or tirzepatide.
  • The "Ozempic soup" label is a marketing frame with no clinical basis.
  • Fiber-rich foods may mildly support endogenous GLP-1 secretion through normal gut physiology, not drug-equivalent mechanisms.
  • If you are managing weight or blood sugar, a registered dietitian or prescribing clinician is the right resource, not a TikTok recipe video.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Leidy · TikTok creator

1.1M views on this video

Sopa Ozempic? Si🙂‍↔️🙂‍↔️🙂‍↔️#paratiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii #bajardepeso #verano

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 0 clinical trials support any food recipe replicating semaglutide?

0 clinical trials support any food recipe replicating semaglutide or tirzepatide receptor binding activity.

What does the video say about fiber intake can modestly stimulate the body's own glp-1 secretion?

Fiber intake can modestly stimulate the body's own GLP-1 secretion through normal gut physiology, per Chambers et al. (2015, Gut), but this is not pharmacologically equivalent to GLP-1 medications.

What does the video say about garlic has shown mild fasting glucose reductions in meta-analysis (ried?

Garlic has shown mild fasting glucose reductions in meta-analysis (Ried et al., 2016, Journal of Nutrition), but these effects are modest and do not translate to drug-equivalent weight loss.

What does the video say about the 'ozempic soup' label on social media?

The 'Ozempic soup' label on social media is a marketing frame with no clinical or regulatory basis, not a description of biochemical activity.

What does the video say about semaglutide (ozempic, wegovy)?

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are FDA-approved prescription medications. Their use requires clinician evaluation, not recipe substitution.

What does the video say about a vegetable broth?

A vegetable broth is a reasonable low-calorie meal, particularly for patients already on GLP-1 therapy managing digestive tolerance, but it works as a light food, not as a drug mimic.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Leidy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.